NeoRx signs supply deal with Cordis
Monoclonal antibody developerNeoRx of Seattle has signed an agreement with catheter maker Cordisof Miami in which Cordis will supply its Micro-Infusion Catheter(MIC) for use with NeoRx's Biostent anti-restenosis product underdevelopment. The MIC will be
Monoclonal antibody developerNeoRx of Seattle has signed an agreement with catheter maker Cordisof Miami in which Cordis will supply its Micro-Infusion Catheter(MIC) for use with NeoRx's Biostent anti-restenosis product underdevelopment. The MIC will be used to deliver Biostent immediatelyafter balloon angioplasty.